The researchers were baffled by the dormant seed's abrupt germination but could not figure out its identification until they ...

Trees have been snapped and tossed, only to land on houses, vehicles and power lines, resulting in considerable concern among organizations that care for the tree population.

NEW YORK, July 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gilead Sciences, Inc. ("Gilead" or the "Company") (NASDAQ: GILD). Such investors are advised ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Gilead Sciences (NASDAQ:GILD) and its peers.

Gilead is betting up to $750 million on Kymera’s anti-CDK2 molecular glue for solid tumors, while Sanofi elected to move forward with another protein degrader from the biotech, designed to target ...

Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention medication, how the twice-yearly antiviral drug Yeztugo works, the ...

Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over its $28K annual price.

Gilead Sciences (GILD) stock gains as the FDA approves the company's twice-yearly injectable lenacapavir, for HIV prevention, under brand Yeztugo. Read more here.

Margaret Atwood’s chilling world of Gilead returns in The Testaments, the long-anticipated sequel to her groundbreaking novel The Handmaid’s Tale. This short dives into the heart of the ...

Blue Moon and skin care company eos have teamed up to introduce an orange-flavored lip balm.

Buddhist temples in China are home to trees from dozens of endangered species, a new study shows. Some of them are almost 2,000 years old.